About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:7408229
Allelic
Composition
Orc1tm1.1Gle/Orc1tm1.1Gle
Tg(Cyp1a1-cre)1Dwi/0
Genetic
Background
involves: C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Orc1tm1.1Gle mutation (0 available); any Orc1 mutation (60 available)
Tg(Cyp1a1-cre)1Dwi mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• the number of cleaved CASPASE-3-positive small intestine crypt cells is increased at 0, 2, 4, and 7 days after beta-napthoflavone (betaNF) treatment
• the number of BrdU-positive small intestine crypt cells is reduced at day 2 but increased by day 4 post-betaNF treatment
• similarly, the number of BrdU/Krt8-double positive crypt cells per small intestine length is reduced at day 2 but increased by day 4 post-betaNF treatment
• at day 2 after the last of 5 consecutive beta-napthoflavone (betaNF) injections, small intestine architecture is severely disrupted, with fewer and smaller crypts and shorter, hypocellular and progressively disorganized villi
• however, by day 4 after the last betaNF injection, ORC1 protein levels are restored to nearly normal levels and a 4- to 5-day repopulation period ensues with enhanced DNA replication, progenitor cell proliferation and crypt hypertrophy such that crypt-villus integrity is fully restored at day 7 post-treatment
• at day 2 post-betaNF treatment, fewer and smaller crypts are observed in the small intestine
• however, crypt integrity is fully restored at day 7 post-betaNF treatment
• at day 2 post-betaNF treatment, small intestine villi are shorter, hypocellular and progressively disorganized
• however, villus integrity is fully restored at day 7 post-betaNF treatment
• small intestine villi are shorter at day 2 but not at day 7 post-betaNF treatment

endocrine/exocrine glands
• at day 2 post-betaNF treatment, fewer and smaller crypts are observed in the small intestine
• however, crypt integrity is fully restored at day 7 post-betaNF treatment

cellular
• the number of cleaved CASPASE-3-positive small intestine crypt cells is increased at 0, 2, 4, and 7 days after beta-napthoflavone (betaNF) treatment
• the number of BrdU-positive small intestine crypt cells is reduced at day 2 but increased by day 4 post-betaNF treatment
• similarly, the number of BrdU/Krt8-double positive crypt cells per small intestine length is reduced at day 2 but increased by day 4 post-betaNF treatment
• DNA replication is enhanced during the 4- to 5-day repopulation period that follows after acute disruption of intestinal integrity

homeostasis/metabolism
• DNA replication is enhanced during the 4- to 5-day repopulation period that follows after acute disruption of intestinal integrity


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/18/2025
MGI 6.24
The Jackson Laboratory